Sign up to save your podcasts
Or
Share Transitioning to Trivalent Flu Vaccines: A Look at the Rationale and Counseling Strategies
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
Transitioning to Trivalent Flu Vaccines: A Look at the Rationale and Counseling Strategies
Host: Charles Turck, PharmD, BCPS, BCCCP
Guest: Christina Madison, BS, PharmD, BCACP, AAHIVP
The World Health Organization and the Vaccines and Related Biologics Products Advisory Committee recently recommended transitioning from quadrivalent to trivalent flu vaccines that exclude the B/Yamagata lineage. Explore the epidemiological data that led to this decision and counseling strategies that can help patients understand this new recommendation with Dr. Charles Turck and Dr. Christina Madison, founder and CEO of the Public Health Pharmacist.
View all episodes
By ReachMDHost: Charles Turck, PharmD, BCPS, BCCCP
Guest: Christina Madison, BS, PharmD, BCACP, AAHIVP
The World Health Organization and the Vaccines and Related Biologics Products Advisory Committee recently recommended transitioning from quadrivalent to trivalent flu vaccines that exclude the B/Yamagata lineage. Explore the epidemiological data that led to this decision and counseling strategies that can help patients understand this new recommendation with Dr. Charles Turck and Dr. Christina Madison, founder and CEO of the Public Health Pharmacist.